PolicyWinds
Topic and direction labels are AI-assisted, and each one quotes the bill text it is based on. How labels work
New York · 2025-2026 General Assembly

A05285 Provides the prescription label for mifepristone or misoprostol may include the address of the dispensing health care practice and shall include the address of the prescribing health care practice at the prescriber's request; provides that a health care prescriber shall inform a patient if such prescriber has included or has requested to include the name or address of the prescribing health care practice instead of the name of such prescriber on the prescription label when prescribing mifepristone or misoprostol.

Direction

Abortion medication abortionAI label

Expands abortion access model confidence 80%

Allows prescribers to request that the prescription label for mifepristone or misoprostol use the practice address/name instead of the prescriber's personal name, and requires patient notification of this choice, which can protect prescriber privacy and reduce risks of harassment or targeting for a

at the prescriber's request, the prescription label for mifepristone or misoprostol shall include the name or address of the prescribing health care practice instead of the name of the prescriber.

✓ Quote verified word for word in the bill text

Abortion provider clinic regulationAI label

No change to abortion access model confidence 70%

Requires health care prescribers to inform patients when they have chosen to include the prescribing health care practice name or address instead of their own name on labels for mifepristone or misoprostol prescriptions.

A health care prescriber shall inform the patient if such prescriber has included or has requested to include the name or address of the prescribing health care practice instead of the name of such prescriber on the prescription label when prescribing mifepristone or misoprostol.

✓ Quote verified word for word in the bill text

  1. Filed (completed)
  2. Committee (completed)
  3. Passed one chamber (completed)
  4. Passed both (completed)
  5. Governor (completed)
  6. Law

Stage: Law · step 6 of 6

Last action
2025-03-20: signed chap.108
Filed
2025-02-12
Sponsor
Karines Reyes D

Why the model tagged it this way: The bill amends labeling rules specifically for mifepristone and misoprostol (medication abortion drugs) to allow practice name/address substitution at prescriber request and mandates patient notification of that choice; this facilitates privacy protections for providers without changing access to the drugs themselves.

Related bills

Hearings and calendar

Votes

DateChamberMotionYea-Nay
2025-02-24AAssembly Higher Education Committee: Favorable refer to committee Rules16-8Passed
2025-02-25AAssembly Rules Committee: Favorable19-8Passed
2025-03-05AAssembly Floor Vote - Final Passage96-51Passed
2025-03-10SSenate Floor Vote - Final Passage40-21Passed

Sponsors

Text versions

History (14 actions)
DateChamberAction
2025-03-20Asigned chap.108
2025-03-20Adelivered to governor
2025-03-10SRETURNED TO ASSEMBLY
2025-03-10SPASSED SENATE
2025-03-10S3RD READING CAL.447
2025-03-10SSUBSTITUTED FOR S4587
2025-03-05SREFERRED TO RULES
2025-03-05Adelivered to senate
2025-03-05Apassed assembly
2025-02-25Aordered to third reading rules cal.103
2025-02-25Arules report cal.103
2025-02-25Areported
2025-02-24Areported referred to rules
2025-02-12Areferred to higher education